首页> 美国卫生研究院文献>Pathogens >Coordinated In Vitro Release of Granulysin Perforin and IFN-γ in TB and HIV/TB Co-Infection Associated with Clinical Outcomes before and after Anti-TB Treatment
【2h】

Coordinated In Vitro Release of Granulysin Perforin and IFN-γ in TB and HIV/TB Co-Infection Associated with Clinical Outcomes before and after Anti-TB Treatment

机译:在抗TB治疗前后与临床结果相关的TB和HIV / TB的颗粒蛋白穿孔素和IFN-γ的体外释放与抗结核病治疗前后的临床结果相关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Granule-associated killing molecules released from cytotoxic T lymphocytes participate as a crucial step in immunity against tuberculosis (TB), but the role of coordinated production remains controversial. Coordinated release of effector molecules in vitro after stimulating peripheral blood mononuclear cells (PBMCs) of active TB or HIV/TB coinfection patients with PPD, purified protein derivative of tuberculin and avirulent , H37Ra, an attenuated strain were investigated in association with clinical outcomes. Perforin, granzyme-B, granulysin and IFN-γ were measured using ELISA. Before anti-TB treatment, PBMCs of TB stimulated with PPD or H37Ra released higher perforin, granzyme-B, and granulysin levels than in HIV/TB and released significantly higher IFN-γ ( = 0.045, = 0.022). Granulysin positively correlated with perforin in TB ( = 0.042, r = 0.385), HIV/TB coinfection ( = 0.003, r = 0.941) after PPD stimulation, and after H37Ra stimulation in TB ( = 0.005, r = 0.549), but negatively correlated with granzyme B in TB ( = 0.042, r = −0.386), HIV/TB coinfection ( = 0.042, r = 0.754) were noted. After anti-TB treatment, increased levels of perforin, granulysin and IFN-γ in TB or HIV/TB upon PPD or H37Ra stimulation, and decreased granzyme-B levels after PPD ( = 0.003) or H37Ra ( = 0.028) stimulation in TB were observed. These results suggest that granulysin may act synergistic with perforin and IFN-γ in TB, indicating its crucial function in host immunity to tuberculosis. Future studies with larger numbers of patients ought to be conducted in the future.
机译:从细胞毒性T淋巴细胞释放的颗粒相关的杀灭分子作为对结核病(TB)的关键阶段,但协调生产的作用仍然存在争议。在刺激活性TB或HIV / TB辛凝聚患者的外周血单核细胞(PBMC)后,在临床结果中研究了临床结果,研究了临床结果的纯化TB或HIV / TB辛纤维患者的效应分子(PBMC),纯化蛋白质衍生物。使用ELISA测量Perforin,Granzyme-B,颗粒蛋白酶和IFN-γ。在抗TB处理之前,用PPD或H37Ra刺激的TB的PBMC释放出高于HIV / TB的PEROIN,Granzyme-B和颗粒蛋白水平,并且释放出明显更高的IFN-γ(= 0.045,= 0.022)。颗粒素在PPD刺激后与Tb(= 0.042,r = 0.385),HIV / Tb辛纤维(= 0.003,r = 0.941)呈正相关,在Tb中的H37ra刺激后(= 0.005,r = 0.549),但呈负相关在Tb中的Granzzyme B(= 0.042,r = -0.386),注意到HIV / TB辛纤维(= 0.042,r = 0.754)。在抗TB处理后,PPD或H37RA刺激的TB或HIV / TB中的穿孔素,颗粒蛋白和IFN-γ水平增加,并在PPD(= 0.003)或H37ra(= 0.028)刺激中降低了Granzyme-B水平观察到的。这些结果表明,颗粒素可以在TB中用穿孔素和IFN-γ协同作用,表明其在宿主免疫中对结核病的关键功能。未来患者的未来研究应该在未来进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号